CHPA Quantifies OTCs’ Overall Value To Promote Expanded Access
This article was originally published in The Tan Sheet
Information from the CHPA-commissioned study could help improve policymakers’ understanding of the costs of making OTCs less available as well as the benefits of more Rx-to-OTC switches.
You may also be interested in...
A bipartisan, bicameral group of lawmakers introduced legislation July 14 to eliminate the prescription requirement to purchase OTC drugs with pre-tax health savings accounts.
The Consumer Healthcare Products Association aims at policymakers and thought leaders with a campaign to reverse the "negative momentum" that threatens the OTC industry with "death by a 1,000 cuts," President and CEO Scott Melville says.
Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.